Get Our Free Research EmailWeekly News and Analysis about the Orthopedic and Dental Industry.
privacy policy · sample email
Conference Calendar
|
Orthopedic and Dental Industry News
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Products ($ in 000's) |
2Q:06 | 2Q:05 | 2Q:06 (% Chg.) |
2Q:06 (% of Sales) |
|
| Spine | $ 425 | $ 483 | -12% | 7% | |
| Dental | 4,338 | 3,102 | 40% | 73% | |
| Surgical Specialties | 1,210 | 1,143 | 6% | 20% | |
| Total - U.S. | $ 5,973 | $ 4,728 | 26% | 100% | |
| Country ($ in 000's) |
2Q:06 | 2Q:05 | 2Q:06 (% Chg.) |
2Q:06 (% of Sales) |
|
| Germany | $ 780 | $ 579 | 35% | 25% | |
| France | 560 | 212 | 164% | 18% | |
| ROW | 1,675 | 1,884 | -11% | 53% | |
| Other | 127 | 151 | -16% | 4% | |
| Total - International | $ 3,142 | $ 2,826 | 11% | 100% | |
| Geography (Revs: $ in 000's) |
2Q:06 | 2Q:05 | Yr./Yr. Chg. (%) |
2Q:06 (% of Sales) |
|
| U.S. | $ 5,973 | $ 4,728 | 26% | 66% | |
| International | $ 3,142 | 2,826 | 11% | 34% | |
| Total Consolidated | $ 9,115 | $ 7,554 | 21% | 100% | |
During the 2Q:06, U.S. revenues increased 26% over the 2Q:05 and represented 66% of TTG's total revenues. TTG's dental and spine products, which had been distributed by Zimmer Dental and Zimmer Spine, achieved mixed results; dental sales increased 40% year-over-year while spine revenues declined 12% compared to 2Q:05.
In the past few months, TTG faced a series of issues: restatement of financials, potential delisting on the American Stock Exchange (AMEX), being named as one of the defendants in the Biomedical Tissues Services (BTS) series of lawsuits and management change. However, the Company seems to be making some progress as this past week it announced that it has received a $3 million private placement and is now in compliance with the AMEX exchange listing requirements. As of noon, TTG stock price was up 10% trading at $4.85.
TTG's management will host a conference call to the investment community on July 12, 2006 at 10:00AM to review results for the quarter.